Status:
ACTIVE_NOT_RECRUITING
Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Imperial College Health Partners
Conditions:
Heart Failure
Heart Valve Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Heart failure (HF) is a condition in which the heart cannot pump blood adequately. It is increasingly common, consumes 4% of the UK National Health Service (NHS) budget and is deadlier than most cance...
Detailed Description
Triple Cardiovascular Disease Detection with Artificial Intelligence-enabled Stethoscope (TRICORDER) is an open label, cluster randomised controlled trial. The aim is to determine whether use of an ar...
Eligibility Criteria
Inclusion
- Primary care practices that care for adult patients and have the ability to request natriuretic peptide blood testing
- Primary care practices within the NIHR North West London Clinical Research Network or Betsi Cadwaladr University Health Board.
Exclusion
- Poor WiFi and/or mobile data connectivity within primary care consulting rooms
- No face-to-face patient consultations
Key Trial Info
Start Date :
October 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05987670
Start Date
October 25 2023
End Date
December 23 2025
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS North West London Integrated Care System
London, United Kingdom